Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP80349.RAdZhaBxfCgp-NzlMwWtras5ZE_MEUrdgLkCMyOBqD2i4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP80349.RAdZhaBxfCgp-NzlMwWtras5ZE_MEUrdgLkCMyOBqD2i4130_assertion type Assertion NP80349.RAdZhaBxfCgp-NzlMwWtras5ZE_MEUrdgLkCMyOBqD2i4130_head.
- NP80349.RAdZhaBxfCgp-NzlMwWtras5ZE_MEUrdgLkCMyOBqD2i4130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80349.RAdZhaBxfCgp-NzlMwWtras5ZE_MEUrdgLkCMyOBqD2i4130_provenance.
- NP80349.RAdZhaBxfCgp-NzlMwWtras5ZE_MEUrdgLkCMyOBqD2i4130_assertion evidence source_evidence_literature NP80349.RAdZhaBxfCgp-NzlMwWtras5ZE_MEUrdgLkCMyOBqD2i4130_provenance.
- NP80349.RAdZhaBxfCgp-NzlMwWtras5ZE_MEUrdgLkCMyOBqD2i4130_assertion SIO_000772 20530282 NP80349.RAdZhaBxfCgp-NzlMwWtras5ZE_MEUrdgLkCMyOBqD2i4130_provenance.
- NP80349.RAdZhaBxfCgp-NzlMwWtras5ZE_MEUrdgLkCMyOBqD2i4130_assertion wasDerivedFrom gad-20150221 NP80349.RAdZhaBxfCgp-NzlMwWtras5ZE_MEUrdgLkCMyOBqD2i4130_provenance.
- NP80349.RAdZhaBxfCgp-NzlMwWtras5ZE_MEUrdgLkCMyOBqD2i4130_assertion wasGeneratedBy ECO_0000203 NP80349.RAdZhaBxfCgp-NzlMwWtras5ZE_MEUrdgLkCMyOBqD2i4130_provenance.